Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06289764
Other study ID # 7/02/2024/131
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 1, 2024
Est. completion date May 30, 2024

Study information

Verified date February 2024
Source Ankara Medipol University
Contact Esra Ö ÖZER, Assist Prof.
Phone +905433630475
Email esra.ozel@ankaramedipol.edu.tr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Aromatherapy is;the science of using highly concentrated essential oils or essences distilled from plants to take advantage of their therapeutic properties. Essential oils or essences are obtained from various parts of plants (root, leaf, flower, bark, fruit) and used therapeutically for physical and psychological well-being. Premenstrual syndrome (PMS) is a health problem characterized by the periodic occurrence of physical, cognitive, emotional and behavioral symptoms during the luteal phase of the menstrual cycle, ending with the onset of menstruation or with the alleviation of symptoms within a few days after the onset of menstruation. It is reported that approximately 80-95% of women complain of PMS complaints. Although the use of aromatherapy in womens health is widespread, there is no study comparing bergamot and grapefruit essential oils. The aim of this study was to determine the effect of aromatherapy with bergamot and grapefruit essential oils on premenstrual syndrome and menstrual symptoms.


Description:

Aromatherapy is the science of using highly concentrated essential oils or essences distilled from plants to take advantage of their therapeutic properties. Essential oils or essences are obtained from various parts of plants (root, leaf, flower, bark, fruit) and used therapeutically for physical and psychological well-being.The fact that aromatherapy is a noninvasive procedure and is easy to use allows aromatherapy to be widely used . Aromatic oils can be applied in four basic ways. These are topical (touch, compress or bath), internal (mouthwash, vaginal or anal suppositories), oral (capsules or dilution in honey, alcohol or diluent) and inhalation (direct or indirect inhalation with or without steam). Essential oils, which can be applied in various ways, can directly reach the neocortex part of the brain through connections from the limbic system to the hypothalamus via odor. As a result of the effect of aromatic oils on the central nervous system, relaxation, sedation or stimulating effects occur, and thanks to the information flow reaching the brain with the stimulation of the central nervous system, the energy blockage in the body is broken and energy is released as a result. The healing process is supported by the balanced spread of the energy flow to the relevant organs, and physical and mental well-being emerges. Aromatherapy is used in many health fields as well as in womens health. Premenstrual syndrome (PMS) is a health problem characterized by periodic physical, cognitive, emotional and behavioral symptoms that occur periodically during the luteal phase of the menstrual cycle, ending with the onset of menstruation or with the alleviation of symptoms within a few days after the onset of menstruation. It is stated that approximately 80-95% of women complain of PMS complaints. In studies in the literature, aromatherapy with various essential oils (rose, geranium, sage, lavender) was applied to women complaining of PMS complaints and it was determined that aromatherapy application had both psychological and physical positive effects by stating that depression, anxiety, anxiety, irritability, and pain perception decreased. Menstrual symptoms are recognized as one of the biggest problems that negatively affect the health status and quality of life among women of reproductive age worldwide. Menstrual symptoms such as dysmenorrhea, heavy menstrual bleeding and mood disorders during the premenstrual period are known to be common in the general population. Menstrual symptoms affect womens activities of daily living and quality of life. In studies in the literature, aromatherapy with various essential oils (rose, sage, ginger) was applied to women with dysmenorrhea, but no study was found in which all menstrual symptoms were measured. Bergamot (Citrus aurantium bergamia), a small tree belonging to the Rutaceae family among citrus fruits, grows in the Mediterranean region and is especially native to the southern coast of Italy. Bergamot essential oil (BEO) is an essential oil produced by extracting the fruit from the rind by cold pressing procedure or steam distillation. Bergamot essential oil has analgesic, sleep quality enhancing, relaxation, anti-inflammatory and antidepressant effects. Grapefruit, one of the citrus families with the largest production in the world, is famous for its taste and nutritional value, and grapefruit essential oil has antibacterial, antimicrobial, antiseptic, antidepressant, anti-edema and appetite regulating effects. Although the use of aromatherapy in womens health is widespread, no study comparing bergamot and grapefruit essential oil has been found. The aim of this study is to determine the effect of aromatherapy application with bergamot and grapefruit essential oils on premenstrual syndrome and menstrual symptoms.


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date May 30, 2024
Est. primary completion date April 20, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria - To be between the ages of 18-35 - Experiencing at least 5 of the pms complaints (self-report) - Not having respiratory diseases such as asthma and bronchitis (self-report) - No pregnancy or suspected pregnancy (self-report) - Not being allergic to any substance (self-report) - Not having a systemic disease such as diabetes, hypertension (self-report) Exclusion Criteria: - Under 18, over 35 years of age Not experiencing pms complaints Finding anosmia Presence of respiratory system diseases Allergic symptoms to aromatherapy Being pregnantHaving a chronic disease

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Bergamot Essential Oil
Selected women will be smelled 3 times a day, at the same time every day, for 4 days, within 7 days before menstruation. Application will be repeated for 3 cycles.
Grapefruit Essential Oil
Selected women will be smelled 3 times a day, at the same time every day, for 4 days, within 7 days before menstruation. Application will be repeated for 3 cycles.
Sweet almond oil
Selected women will be smelled 3 times a day, at the same time every day, for 4 days, within 7 days before menstruation. Application will be repeated for 3 cycles

Locations

Country Name City State
Turkey Ankara Medipol Universty Ankara Altindag

Sponsors (2)

Lead Sponsor Collaborator
Esra ÖZER KTO Karatay University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Premenstrual syndrome scale (PMS) It is a five-point Likert type scale consisting of 44 questions measuring the severity of premenstrual symptoms. A minimum of 44 and a maximum of 220 points can be obtained from the scale. An increase in the score obtained from the scale indicates that the intensity of PMS symptoms increases. In the PMS scale, PMS is considered to be "present" if it exceeds 50% (110) of the total scale score (220). Baseline and three months later
Secondary Menstrual Symptom Scale Scale items are numbered according to the allocated factors for ease of use. 1-13. Items belong to the "Negative effects/somatic complaints" subscale, items 14-19. The items refer to the "Menstrual pain symptoms" subscale and items 20-22. The items belong to the "Coping methods" sub-dimension. Cronbach's Alpha value is 0.86. It is a five-point Likert type scale consisting of 22 items. The score obtained from the sub-dimensions is calculated by taking the total score average of the items in the sub-dimensions. Average score for sub-dimensions Its increase indicates that the severity of menstrual symptoms related to that sub-dimension increases. Baseline and three months later
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02402049 - Homeopathic Treatment of Premenstrual Syndrome Phase 3